ICU Medical ICUI Government Grant Revenue — Revenue, Remaining Performance Obligation, Amount

Other product segments

Similar metrics at other companies

CPKTotal revenue contracts with remaining performance obligations — Revenue, Remaining Performance Obligation, Amount

$121.3M-12.5%

STRLBuilding Solutions Revenues — Revenue, Remaining Performance Obligation, Amount

$49.32M-3.5%

STRLTransportation Solutions Revenues — Revenue, Remaining Performance Obligation, Amount

$1.04B+20.3%

GHC

GHCKaplan International — Revenue, Remaining Performance Obligation, Amount

$199.8M-22.8%

GHC

GHCSupplemental Education — Revenue, Remaining Performance Obligation, Amount

$4.1M-32.8%

STRLE-Infrastructure Solutions Revenues — Revenue, Remaining Performance Obligation, Amount

$2.71B+123%

FAQ

What is ICU Medical's government grant revenue — revenue, remaining performance obligation, amount?

ICU Medical (ICUI) reported government grant revenue — revenue, remaining performance obligation, amount of $4.34M in Q2 2026.

How has ICU Medical's government grant revenue — revenue, remaining performance obligation, amount changed year-over-year?

ICU Medical's government grant revenue — revenue, remaining performance obligation, amount decreased by 31.3% year-over-year, from $6.32M to $4.34M.

What is the long-term trend for ICU Medical's government grant revenue — revenue, remaining performance obligation, amount?

Over 3 years (2022 to 2025), ICU Medical's government grant revenue — revenue, remaining performance obligation, amount has grown at a -22.9% compound annual growth rate (CAGR), from $52.9M to $24.23M.

What does government grant revenue — revenue, remaining performance obligation, amount mean?

This metric quantifies the total transaction price allocated to government grant performance obligations that are unsatisfied or partially unsatisfied as of the reporting date. It provides visibility into the future revenue expected to be recognized as the company fulfills its contractual or regulatory obligations tied to government funding. Investors use this to assess the durability and future revenue visibility of the company's grant-funded initiatives.